ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.37 USD 1.48% Market Closed
Market Cap: 229.9m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Total Receivables Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Total Receivables
$2.3m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Total Receivables
€17B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Merck KGaA
XETRA:MRK
Total Receivables
€4.8B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Total Receivables
€1.8m
CAGR 3-Years
258%
CAGR 5-Years
109%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Total Receivables
€113.2m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Total Receivables
€9.4m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Total Receivables?
Total Receivables
2.3m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Total Receivables amounts to 2.3m USD.

What is ATAI Life Sciences NV's Total Receivables growth rate?
Total Receivables CAGR 3Y
20%

Over the last year, the Total Receivables growth was -78%. The average annual Total Receivables growth rates for ATAI Life Sciences NV have been 20% over the past three years .

Back to Top